Global Discovery Lipidomics
Lipids are not only essential structural and energy-storage components in living systems, but also play key roles in cell signaling, membrane integrity, and a wide range of physiological processes. Lipidomics research is critical for elucidating disease mechanisms, enabling early diagnosis, and informing therapeutic strategies.
Powered by micro/nano-material LDI-MS technology, Global Discovery (Lipidomics) offers a high-coverage, untargeted lipidomics platform that delivers a new and powerful approach for biomedical research.
Product Consultation
Serum Lipidomics Applied to Early Screening of Liver Cancer and Biomarker Discovery for Disease Progression
Journal: Anal. Chem. Published: May 2022 Impact Factor: 8.008
DOI: 10.1021/acs.analchem.1c04929
In this study, the authors enrolled a total of 133 volunteers, including 76 healthy controls and 57 patients with hepatocellular carcinoma (HCC). Using HuiJian Technology’s micro-nano mass spectrometry chip combined with a high-resolution MALDI-TOF mass spectrometer, they established a high-coverage serum lipidomics analysis platform to identify potential lipid biomarkers in the serum of liver cancer patients.